Propiconazole 10.7% + Tricyclazole 34.2% SE (CAS NO : 41814-78-2)

Propiconazole 10.7% + Tricyclazole 34.2% SE (CAS 60207-90-1 and CAS 41814-78-2) is increasingly becoming a focal point in the United States API intermediates market as US-based CDMOs seek high purity fine chemicals for the localized synthesis of complex agro-pharmaceutical hybrids. This synergistic suspension emulsion, often identified as 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1,2,4-triazole combined with 5-methyl-1,2,4-triazolo[3,4-b][1,3]benzothiazole, is essential for high-performance industrial use where a general industry purity 98% is required to meet rigorous EPA and American Chemical Society standards for specialty chemical precursors. As the industry navigates global sourcing shifts, the demand for a reliable bulk chemical supplier offering custom synthesis services has surged, particularly for those providing Pharma/API purity 99% versions utilized in advanced research for systemic fungal inhibition and metabolic pathway modeling. As an established agrochemical and specialty chemical suppliers in the united states, we ensure dependable supply, consistent quality, and complete regulatory documentation, including CoA and TDS across all grades. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, and analytical method development to scale-up, process optimisation, and pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and global supply chain and logistics coordination.